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Nicotinic acid inhibits glioma 
invasion by facilitating Snail1 
degradation
Jiejing Li1,4,*, Jiagui Qu1,*, Yu Shi2,3,*, Mark Perfetto4,5,*, Zhuxian Ping1, Laura Christian4, 
Hua Niu1, Shuting Mei6, Qin Zhang1, Xiangcai Yang1 & Shuo Wei4,5
Malignant glioma is a formidable disease that commonly leads to death, mainly due to the invasion 
of tumor cells into neighboring tissues. Therefore, inhibition of tumor cell invasion may provide an 
effective therapy for malignant glioma. Here we report that nicotinic acid (NA), an essential vitamin, 
inhibits glioma cell invasion in vitro and in vivo. Treatment of the U251 glioma cells with NA in vitro 
results in reduced invasion, which is accompanied by a loss of mesenchymal phenotype and an increase 
in cell-cell adhesion. At the molecular level, transcription of the adherens junction protein E-cadherin 
is upregulated, leading to accumulation of E-cadherin protein at the cell-cell boundary. This can be 
attributed to NA’s ability to facilitate the ubiquitination and degradation of Snail1, a transcription 
factor that represses E-cadherin expression. Similarly, NA transiently inhibits neural crest migration in 
Xenopus embryos in a Snail1-dependent manner, indicating that the mechanism of action for NA in cell 
migration is evolutionarily conserved. We further show that NA injection blocks the infiltration of tumor 
cells into the adjacent brain tissues and improves animal survival in a rat model of glioma. These results 
suggest that NA treatment may be developed into a potential therapy for malignant glioma.
Malignant glioma is a type of tumor that derives from the glial cells in the nervous system, including those of 
neural crest origin1,2. Patients commonly succumb to this deadly disease within 5 years upon being diagnosed3. 
Glioma is classified into four distinctive pathological grades according to the World Health Organization (WHO). 
Among them, grade IV, also called glioblastoma multiforme (GBM), is recognized clinically as the most frequent 
and malignant category4. Currently, therapeutic strategies involve three approaches, which consist of maximal 
tolerable surgical resection paired with radiation and chemotherapy. The combination of these therapies is able 
to add only months of additional survival. The diffuse invasion of tumor cells into the surrounding brain tissues 
imparts the major challenge for therapy. Although early radical surgical interventions attempt to remove the 
entire affected brain hemisphere, patients are usually subjugated to cancer cells that had crossed into the other 
hemisphere5. Even now, with advanced microsurgical techniques, recurrence is still often inevitable. Glioma typ-
ically reoccurs within 1–2 cm of the primary tumor6. Hence, a primary challenge is to prevent glioma cells from 
uncontrolled migration and subsequent infiltration into other brain regions.
Cell migration is a finely tuned biological process that often involves epithelial–mesenchymal transition 
(EMT). EMT was initially defined in the early 1980s by Elizabeth Hay7, who described changes from epithelial 
to mesenchymal phenotype in the primitive streak of chick embryos. EMT is a process that is associated with 
remarkable changes in cell adhesion, polarity and migratory properties. During EMT, epithelial cells lose their 
adhesion and polarity, reorganize their cytoskeleton, and undergo changes in cell signaling that alter cell shape 
and reprogram gene expression. EMT is typically characterized by upregulation of mesenchymal markers such as 
Snail1 and downregulation of epithelial markers such as E-cadherin. This process has been shown to be of critical 
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importance to normal developmental processes such as mesoderm and neural crest migration8,9. Interestingly, 
similar mechanisms are utilized in disease processes including wound healing, fibrosis and tumor metastasis10–12. 
Notably, EMT and EMT-like processes confer tumor cells with the ability to migrate, invade, and adopt stem 
cell-like properties that largely account for immunosuppression and tumor recurrence13,14. Therefore, suppressing 
EMT should contribute to cancer therapy in multiple facets.
Nicotinic acid (NA), a member of the vitamin B family, is well known for its functions in the treatment and 
prevention of atherosclerosis. NA is one of the most effective agents that provide protection against cardiovascu-
lar risk factors by decreasing low-density and very low-density lipoprotein levels, while simultaneously increas-
ing high-density lipoprotein levels15. Mechanistically, NA has been shown to downregulate cyclic adenosine 
monophosphate, the major intracellular mediator of pro-lipolytic stimuli, thereby decreasing cellular levels of 
free fatty acids16. Recently, we and others reported that NA is also able to regulate intracellular calcium levels. Ma 
et al. demonstrated that a high concentration (50 mM) of NA can regulate the activities of heat-sensitive capsaicin 
receptors TRPV1–4, which are non-selective calcium-permeable cation channels. Meanwhile, we found that NA 
causes a transient reduction but subsequent elevation in free intracellular [Ca2+] in NIH 3T3 cells. Treatment 
with over 30 mM NA further leads to disassembly of the cytoskeleton in 3T3 cells and inhibition of intracellu-
lar melanosome transport in Xenopus embryos, effects that can be partially attributed to increased intracellular 
[Ca2+]17–19.
In the current study we assessed the effects of NA on the behavior of glioma cells. We found that NA inhibits 
the invasion of U251 GBM cells by facilitating the ubiquitination and degradation of Snail1, a transcription factor 
that promotes EMT. This mechanism is likely conserved through evolution, as NA also downregulates Snail1 lev-
els and delays neural crest migration in Xenopus embryos. We also show that NA treatment inhibits the invasion 
of C6 glioma cells allografted in the rat brain and improves survival of these rats. Based on these data, we propose 
that NA treatment may be developed into an effective therapeutic method for malignant glioma.
Results
In vitro NA treatment causes loss of mesenchymal phenotype and reduced invasion of U251 cells. 
We reported previously that high concentration of NA is able to disrupt cytoskeletal structures in 3T3 cells17. 
To assess if NA has any potential effects on malignant glioma, we treated cultured U251 GBM cells with various 
concentrations of NA. High concentrations of NA (14 mM and above) detached U251 cells and led to apoptosis 
(Yang X. et al., manuscript in preparation). By contrast, up to 7.0 mM NA did not cause any detectable cell death 
even after a prolonged period of treatment, as manifested by low annexin V and propidium iodide (PI) staining 
in the majority of cells with or without NA treatment (20 hr; Fig. S1A-S1D). However, we noticed a significant 
change in cell morphology with increasing concentrations of NA. The untreated U251 cells were mostly elongated 
and mesenchymal-like (Fig. 1A–D). Staining for F-actin and β -tubulin reveals that, similar to U87 GBM cells20, 
U251 cells often formed long protrusions that are primarily made of microtubules but also contain some actin fila-
ments (white arrowheads in Fig. 1D,H; inset in Fig. 1D). Upon treatment with 3.5 mM NA, some of the U251 cells 
became rounded (Fig. 1E–H), whereas 7.0 mM NA caused most cells to lose the mesenchymal phenotype and long 
Figure 1. U251 cells lose mesenchymal phenotype upon NA treatment. U251 cells were incubated with 
PBS (control) or the indicated concentration of NA for 8 hr. Rhodamine phalloidin labeling for F-actin (red), 
immunocytochemistry for β -tubulin (green) and DAPI labeling for nuclei (blue) were carried out as described 
in Methods. White arrowheads denote the long protrusions that consist mainly of microtubules, and the inset 
in (D) shows an amplified image of the indicated protrusion. The percentage of cells with this type of long 
protrusions was calculated for each treatment and summarized in (F). *P < 0.05; ***P < 0.001.
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protrusions. Such a morphological change was accompanied by alterations in cytoskeletal structure: long F-actin 
stress fibers were significantly reduced, and microtubules became more uniformly distributed throughout the cells 
(Fig. 1I–L).
Although most U251 cells treated with NA still retained their actin-based filopodia, the significant reduction 
of cells with long protrusions that consist mainly of microtubules (Fig. 1M) suggests that NA may interfere with 
the migration/invasion of U251 cells, as the motility of GBM cells has been shown to be independent of actin 
polymers but dependent on microtubule assembly20. To assess this possibility, we performed Boyden chamber 
invasion assays. The invasive ability of U251 cells was considerably decreased with increasing concentrations of 
NA, as indicated by fewer cells that migrated through the matrigel (Fig. 2A–D) and more cells that were retained 
on the original seeded side (Fig. 2E–H). Thus NA inhibits the invasive ability of U251 cells, a main feature of GBM 
cells that contributes to high lethality. We further tested if NA affects the invasion of other types of cancer cells. 
As shown in Fig. S2A-S2H, 3.5 and 7.0 mM NA also reduced the invasive abilities of U87 GBM cells and B16F10 
melanoma cells, suggesting that NA’s effect on cell invasion is not limited to U251 cells.
NA upregulates cell-cell adhesion by promoting Snail1 ubiquitination and degradation in U251 cells. 
A characteristic of migratory mesenchymal-like cells, as opposed to non-migratory epithelial-like cells, is weaker 
cell-cell adhesion. We therefore examined if NA treatment of U251 cells affects cell-cell adhesion. Western blot 
and quantitative RT-PCR (RT-qPCR) analyses reveal that treatment of U251 cells with 3.5 and 7.0 mM NA for 
4 hr resulted in upregulated protein and mRNA levels of E-cadherin (Fig. 3A,B,D,E), a major component of the 
adherens junctions. This was further validated by immunocytochemistry results, which show that there was an 
increase in E-cadherin signal at the cell-cell boundaries upon NA treatment (Fig. 3G–J). Similarly, tight junction 
protein ZO-1 also increased drastically (Fig. S3A-S3C), suggesting that overall cell-cell adhesion was enhanced.
EMT is a common mechanism that cells of the epithelial origin utilize to initiate migration during developmental 
processes and tumor metastasis21. A hallmark of EMT is the downregulation of cell-cell adhesion molecules such as 
E-cadherin and ZO-1. Because glial cells are developmentally derived from the neuroepithelial lineage, and glioma cells 
are known to undergo EMT-like process to become invasive22,23, the upregulation of both E-cadherin and ZO-1 indi-
cates that the EMT-like process is inhibited in U251 cells treated with NA. The zinc-finger transcription factor Snail1 
is able to recruit several chromatin-modifying enzymes to the E-cadherin promoter, thereby epigenetically silencing 
E-cadherin expression in migratory tumor cells24,25. Although Snail1 does not seem to regulate the transcription of 
ZO-1, ectopically expressed Snail1 has been shown to reduce ZO-1 protein levels post-transcriptionally26. Hence we 
went on to assess the effects of NA treatment on Snail1 expression. Incubation of U251 cells in increasing concentra-
tions (3.5 and 7.0 mM) of NA for 4 hr resulted in decreasing levels of Snail1 protein (Fig. 3A,C), which correlated well 
with increasing levels of E-cadherin protein and mRNA (Fig. 3B,E). However, no decrease in snail1 transcript was 
detected (Fig. 3D,F), indicating that the regulation of Snail1 by NA is post-transcriptional.
Figure 2. NA treatment inhibits U251 cell invasion in vitro. Transwell assays were carried out for U251 
cells incubated in PBS (control) or the indicated concentration of NA as described in Methods. Images of cells 
(stained with Giemsa) that invaded through the matrigel (A–C) or remained on the seeded side  
(E–G) in a representative experiment are shown, and results of 15 different regions in 3 independent 
experiments (5 regions per experiment) are summarized in (D) and H for the opposite and seeded sides, 
respectively.
www.nature.com/scientificreports/
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Because Snail1 is known to be degraded through the ubiquitin-proteasome pathway27, we asked if NA regu-
lates Snail1 ubiquitination and/or degradation. Pre-treatment of U251 cells with the proteasome inhibitor MG132 
abolished the effect of 7.0 mM NA on Snail1 protein levels, and co-immunoprecipitation (co-IP) assays detected 
elevated levels of ubiquitin associated with Snail1 upon treatment with NA (Fig. 3K). Together these results sug-
gest that NA boosts ubiquitin-proteasome-mediated Snail1 degradation as well as cell-cell adhesion.
To determine if the regulation of cell-cell adhesion by NA depends on its ability to promote Snail1 degrada-
tion, we tested if exogenously overexpressed Snail1 could reverse the increase in E-cadherin level in NA-treated 
U251 cells. As shown in Fig. 4A–F, overexpression of Snail1 did abrogate the effects of NA on inducing the mRNA 
and protein expression of E-cadherin. Immunocytochemistry data further confirm the loss of E-cadherin at 
cell-cell boundaries caused by Snail1 re-expression (Fig. 4G–L). We conclude from the above data that NA upreg-
ulates cell-cell adhesion in U251 cells by facilitating the ubiquitination and turnover of Snail1.
Injection of NA leads to reduced Snail1 levels and delayed neural crest migration in Xenopus 
embryos. The vertebrate neural crest cells are highly migratory stem cells that are induced at the neural plate 
border (NPB) during gastrulation. These cells subsequently undergo EMT to delaminate from the closing neural 
tube, migrate to various destinations and give rise to a wide range of derivatives including neurons and glia of 
the peripheral nervous system28. Similar to cancer cells, migration of neural crest cells from the neural tube also 
depends on transcription factors that regulate EMT, including Snail1 and Snail28. The Xenopus cranial neural 
crest (CNC) is frequently used as an easily accessible and manipulable in vivo model for studying the mechanisms 
underlying EMT29–32. To test if NA regulates EMT and migration of CNC cells, we injected 70 ng NA into one cell 
of 2-cell stage Xenopus embryos (with a final NA concentration of ~5 mM). In vitro transcript of β -galactosidase 
was co-injected as a lineage tracer, and the uninjected side served as a negative control. The induction of CNC 
can be subdivided into two steps: the initial formation of the NPB, as indicated by the expression of transcription 
factors such as Pax3, Zic1 and Msx1 (also called NPB specifiers), and subsequent specification of the CNC, as 
indicated by the expression of another set of transcription factors such as Snail1 and Snail2 (also called CNC 
Figure 3. NA upregulates E-cadherin expression by promoting ubiquitination and degradation of Snail1. 
U251 cells were treated with PBS (control) or the indicated concentration of NA for 4 hr. (A–C) Western blot 
analyses for whole-cell lysates were performed with an anti-E-cadherin antibody. Membranes were stripped  
and reblotted for Snail1 and β -actin. Representative images of Western blots are shown in A, and relative 
intensity of E-cadherin and Snail1 normalized against β -actin was calculated and summarized in  
(B,C), respectively. (D–F) Total RNA was extracted, and RT-PCR was carried out for the transcripts of 
E-cadherin, snail1, and GAPDH. Representative images of semi-quantitative RT-PCR are shown in (D) and 
relative expression levels of E-cadherin and snail1 (normalized against GAPDH), as determined by RT-qPCR, 
are shown in (E,F) respectively. NS, not significant; **P < 0.01; ***P < 0.001. (G–J) Cells were fixed and 
processed for DAPI staining (blue) and immunocytochemistry for E-cadherin (green). (K) U251 cells were 
treated with MG132 and NA or PBS (control), IP was carried out for cell lysates with an anti-Snail1 antibody, 
and Western blot was performed with an anti-ubiquitin antibody. Western blot for whole-cell lysates (WCL) was 
also performed separately with an anti-Snail1 antibody.
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specifiers)33,34. Notably, some of the CNC specifiers, including both Snail1 and Snail2, also control EMT and 
CNC migration at later stages (see discussion above). At late gastrula stage (stage ~12) when the CNC had just 
been induced, we did not observe any effect of NA on the expression of any of the NPB specifiers (msx1, pax3, 
or zic1) or CNC specifiers (snail1 or snail2), suggesting that both steps of CNC induction occurred normally 
(Fig. S4A-S4F). At stage ~18, the CNC had emerged from the neural tube and started to migrate in three separate 
streams (Fig. 5A). By contrast, in embryos injected with NA, the CNC failed to migrate from the neural tube on 
the injected side, although it migrated normally on the uninjected side (Fig. 5B,D). At stage ~20 (several hours 
later), CNC started to migrate in three streams on the injected side (data not shown), probably because NA was 
metabolized by this time. Thus NA transiently inhibited CNC migration but had no effect on the induction of 
CNC.
One possible explanation for the delayed CNC migration is that NA decreases the levels of EMT inducers 
such as Snail1, as we observed in U251 cells in vitro. To test this hypothesis, we injected embryos with an mRNA 
encoding myc-tagged Xenopus Snail1, and compared the levels of exogenously expressed Snail1 in embryos 
with and without co-injected NA. Both whole embryo lysates and dissected CNC showed reduced Snail1 pro-
tein levels upon NA treatment (Fig. 5E–G), although the amount of injected Snail1-myc mRNA was the same 
in embryos with and without NA co-injection. This is consistent with the ability of NA to downregulate Snail1 
post-transcriptionally, as we observed in U251 cells (Fig. 3). To further assess if NA interferes with CNC migration 
via Snail1, we took advantage of an inducible Snail1-glucocorticoid receptor (GR) fusion protein, which resides in 
the cytoplasm until addition of the GR agonist dexamethasone triggers Snail1 nuclear import35. Dexamethasone 
was added at the beginning of gastrulation (stage 10–10.5) to avoid earlier developmental defects that could be 
caused by Snail1 overexpression. As shown in Fig. 5C,D, overexpression of Snail1 completely rescued the delayed 
Figure 4. Snail1 reverses the effects of NA on E-cadherin expression. U251 cells were treated with PBS 
(control) or 7.0 mM NA for 4 hr, or transfected with a plasmid expressing Snail1 and then treated with 7.0 mM 
NA for 4 hr. (A) Western blot analyses for whole-cell lysates were performed with an anti-E-cadherin antibody. 
Membranes were stripped and reblotted for Snail1 and β -actin. Representative images of Western blots are 
shown in A, and relative intensity of E-cadherin and Snail1 normalized against β -actin was calculated and 
summarized in (B,C) respectively. (D–F) Total RNA was extracted, and RT-PCR was carried out for the 
transcripts of E-cadherin, snail1, and GAPDH. Representative images of semi-quantitative RT-PCR are shown in 
(D), and relative expression levels of E-cadherin and snail1 (normalized against GAPDH), as determined by RT-
qPCR, are shown in E and F, respectively. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001. (G–L) Cells 
were fixed and processed for DAPI staining (blue) and immunocytochemistry for E-cadherin (green).
www.nature.com/scientificreports/
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CNC migration caused by NA. These results suggest that similar to the inhibition of EMT-like process and inva-
sion in U251 cells, NA exerts its effect on CNC migration through regulation of Snail1.
NA treatment blocks glioma cell invasion and improves survival in vivo. Given the effects of NA 
on the U251 GBM cells in vitro and Xenopus CNC in vivo, it was tempting to evaluate if NA can block glioma 
invasion in an animal model. To this end we allografted rats with C6 glioma cells, and conducted on-site NA 
injections starting from day 4 after grafting. A single dosage of 31 μ g NA (5 μ l of 50 mM NA) was injected into 
the allograft everyday for 20 consecutive days. We then sacrificed the rats and assessed the infiltration of tumor 
cells into normal brain tissues by examining 5 randomly selected allograft regions in brain slices collected from 
each rat. As compared with normal brain tissues, H&E stained C6 cells displayed nuclear atypia that is charac-
teristic of high-glade glioma (arrows in Figs 6A,B and S5). In the control group injected with PBS, C6 glioma 
cells frequently infiltrated into normal brain tissues, and only < 5% of all chosen regions had a clear boundary 
between tumor and normal brain (Figs 6A,C,E,G and S5A-S5C). By contrast, in > 60% of the chosen regions in C6 
allografted rats treated with NA, we observed a clear boundary with fewer tumor cells infiltrating normal brain 
tissues (Figs 6B,D,F,G and S5D-S5F). The intermediate filament protein Nestin is abundantly expressed in certain 
high-grade gliomas as well as embryonic cerebrum, but not in normal adult brain tissues36,37. Our immunohis-
tochemistry results for Nestin show less intermingling between tumor and non-tumor cells in NA-treated brain 
slices as compared with control (Fig. 6H–M), further confirming that NA inhibits the infiltration of C6 glioma 
cells into normal brain tissues. Finally, we determined if NA can improve the survival of C6-allografted rats. As 
shown in Fig. 6N, ~70% of the allografted rats that were continuously administered with NA were still alive on 
day 58. This is in stark contrast with the control group, which all died by day 24 (Fig. 6N). Thus NA displayed 
significant beneficial effects on glioma in vivo.
Discussion
Although NA and its derivatives have been intensively studied for decades, new functions and mechanisms 
of action for them continue to emerge. Recently, we reported that treatment of 3T3 cells with high concentra-
tions of NA leads to dynamic changes in intracellular calcium concentration and disassembly of the cytoskeletal 
Figure 5. NA inhibits CNC migration in Xenopus embryos by inducing Snail1 degradation. (A–D) Xenopus 
embryos were injected in one blastomere at 2-cell stage with PBS (control; A), NA (70 ng; B), or NA combined 
with mRNA encoding GR-fused Snail1 (C). To induce nuclear translocation of Snail1, dexamethasone was 
added at stage 10–10.5 (C). Embryos were cultured to stage ~18 and processed for in situ hybridization for 
snail2. The injected side (on the right and denoted with an asterisk) was labeled with co-injected β -galatosidase 
(red), and arrows indicate the directions of migration of the three CNC streams. A representative embryo from 
each group is shown in (A–C), and quantitative results are summarized in (D). (E) Embryos were injected with 
mRNA encoding myc-tagged Snail1, and cultured with or without NA until stage 15–17 (shortly before CNC 
migration). Western blot was carried out with an anti-myc antibody for whole-embryo lysates or lysates of 
dissected CNC. Representative images of Western blots are shown in (E), and relative intensity of myc-tagged 
Snail1 normalized against β -actin was calculated and summarized in (F) (whole embryos) and (G) (CNC). 
*P < 0.05.
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structures17. These observations prompted us to test if NA has any effects on malignant glioma cells, which are 
known for their high invasive activity. We found that treatment with relatively lower concentrations of NA caused 
loss of mesenchymal phenotype in U251 cells and inhibited glioma invasion in vitro and in vivo. At the molecular 
level, NA promoted Snail1 degradation and enhanced cell-cell adhesion, suggesting inhibition of an EMT-like 
process in glioma cells.
The roles of EMT in glioma cell migration remain controversial, mainly due to the physiological difference 
between glial and epithelial cells along with the lack of an E-cadherin to N-cadherin switch, which is charac-
teristic of EMT, in glioma cells38,39. In fact, most malignant glioma cells express very low levels of endogenous 
E-cadherin (Figs 3 and 4)39–41. However, accumulating evidence in the recent years strongly indicates the exist-
ence of an EMT-like process, sometimes referred to as “glial-to-mesenchymal transition”, that plays important 
roles in regulating GBM cell invasion39–41. A key observation was that the majority of GBM cells are mesenchymal 
(Fig. 1)39–41, providing an explanation for the lack of E-cadherin expression and high invasive activity of these 
cells. While multiple EMT regulators are involved in controlling the mesenchymal phenotype of GBM cells, the 
zinc-finger transcription factor Snail1 is of particular interest. Snail1 expression correlates well with WHO tumor 
grade, and is elevated in clinically recurrent malignant glioma after treatment with ionizing irradiation42–44. 
Depletion of Snail1 causes reduced expression of mesenchymal markers and loss of mesenchymal phenotype, 
Figure 6. NA injection inhibits C6 glioma cell invasion in vivo and improves survival in a rat model of 
glioma. Rats allografted with C6 cells were injected with PBS (control) or NA as described in Methods.  
(A–G) Brain slices were collected and H&E staining was carried out. Representative images of brain slices 
collected from rats injected with PBS or NA are shown in (A–F) (with indicated magnification), and 
quantitative results from both groups (6 rats/group) are summarized in G. Arrows indicate C6 glioma cells. 
***P < 0.001. (H–M) Brain slices were processed for DAPI staining (blue) and immunocytochemistry for Nestin 
(red). (N) NA significantly improved the survival of C6-allografted rats as compared with control (PBS; n = 25 
for each group, P < 0.001).
www.nature.com/scientificreports/
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as well as inhibition of GBM cell invasiveness in vitro and in vivo42,43,45–47. These effects are accompanied by an 
increase in E-cadherin level similar to what we observed here with NA treatment45,47 (Figs 3 and 4), suggesting 
that E-cadherin expression is normally repressed by Snail1 in malignant glioma, and that such a repression is 
reversible. Thus at least some malignant glioma cells can be considered as cells that have undergone a reversi-
ble EMT-like process to become mesenchymal and invasive, and NA treatment may provide a novel method to 
reverse this process and inhibit the invasion of these tumor cells.
The molecular mechanisms that regulate neural crest EMT and migration are evolutionarily conserved and 
highly similar to the mechanisms that regulate cancer EMT and migration/invasion8,48,49. In addition, recent evi-
dence suggests that some types of glioma are neural crest-derived1,2, making the neural crest an excellent model 
for studying glioma cell invasion. For instance, a recent study shows that chemical compounds that inhibit CNC 
migration in Xenopus embryos also inhibit GBM cell invasion in mice50. In the current study we found that NA 
promotes degradation of Snail1, a major EMT regulator whose function is evolutionarily conserved8,48,49, in both 
U251 GBM cells and the Xenopus CNC. This finding provides another example of the close relationship between 
developmental and pathological EMT, and supports the use of non-mammalian vertebrates such as Xenopus as 
simple and more accessible models to identify and characterize drug candidates for cancer therapy. Furthermore, 
the inhibition of CNC migration by NA in Xenopus embryos also implies a potential risk of CNC-related birth 
defects in babies whose mothers take high dosages of NA during early pregnancy (e.g., for treating cardiovascular 
diseases).
To better evaluate the therapeutic potential of NA, it is important to understand the mechanism of action for 
NA in malignant glioma. At this point it is not clear if the inhibition of glioma invasion by NA is related to its abil-
ity to elevate intracellular calcium levels, as we reported previously for 3T3 cells17, but we did observe transient 
calcium spikes in U251 cells induced by 3.5 and 7.0 mM NA (data not shown). In addition, activation of either 
hydroxyl-carboxylic acid receptor 2 (HCA2; previously known as GPR109A or HM74a) or TRPV channels, two 
types of NA receptors, can induce calcium influx51,52. Current efforts are therefore focused on testing if blocking 
calcium signaling can interfere with the effects of NA on glioma invasion. The studies of NA as a vitamin in 
glioma pathology can be traced back to more than half a century ago53. Nicotinamide, the amide of NA that has 
the same vitamin function but does not affect lipid metabolism54, has also been shown to have tumor suppressor 
activity55,56. However, our preliminary results suggest that nicotinamide does not mimic NA in causing any of the 
effects on glioma cells that we observed here (data not shown). Moreover, the concentrations of NA that we used 
to achieve an inhibition of U251 cell invasion in vitro (mM level) were much higher than the recommended daily 
dosage of NA as a vitamin, but comparable to those used for preventing cardiovascular diseases57. Thus instead 
of functioning as a vitamin, NA likely inhibits glioma invasion through specific receptors such as HCA2 and/or 
TRPVs, which do not respond effectively to nicotinamide19,58. Interestingly, both HCA2 and TRPVs have been 
shown to regulate PI3K/Akt signaling59–61, a signaling pathway that is upstream to control GSK-3β -mediated 
phosphorylation and subsequent ubiquitination of Snail162,63. Hence it will be of interest to investigate if NA 
affects the activation of GSK-3β and/or Akt and, if so, how these effects are related to intracellular calcium levels. 
Another important question is whether NA could induce the differentiation of glioma stem cells, as reported 
recently for other anti-cancer drugs such as taxol64. Although we did not observe any apparent changes in the 
level of stemness marker Nestin or differentiation marker β -tubulin with immunostaining (Figs 1 and 6J,K), 
more quantitative methods such as real-time RT-PCR and Western blot are needed to determine if there are any 
relatively subtle effects of NA on glioma differentiation.
The inhibition of GBM invasion in vivo by NA (Fig. 6) suggests that it can be used prior to surgery to prevent 
tumor recurrence. Additionally, 5-fluorouracil (5-FU), an antimetabolite that is being actively tested for treatment 
of malignant glioma65, has been reported to cause NA deficiency66. This raises an intriguing possibility of using 
NA in combination with 5-FU for treating malignant glioma. Given that Snail1 is a key EMT regulator in many 
types of cancer, it is also possible that NA has beneficial effects on other invasive tumors. Indeed, our results sug-
gest that the invasion of malignant melanoma cells is also inhibited by NA (Fig. S2E-S2H), pointing to a general 
role of NA in regulating tumor invasion.
NA is widely used as an antidyslipidemic drug, and the abundant safety data that are available may greatly 
facilitate its potential future trials in other diseases such as cancer. We show here that daily injections of 5 μ l of 
50 mM NA were able to inhibit C6 GBM cell invasion and improve the survival of allografted rats. The overall 
dosage (31 μ g per rat per day) was equivalent to or slightly below the dietary intake reference for NA as a vitamin 
(14–18 mg per person per day). Therefore, we do not expect any severe side effects on the other parts of the body. 
However, whether the initial high local concentration of NA could lead to damages to surrounding neurons or 
glia in the brain remains to be examined. Other potential adverse effects that could be caused by the transient 
high local concentration of NA include flushing54. Flushing is mediated by HCA2 and TRPV channels, which may 
also mediate the anti-tumor activity of NA that we report here. Fortunately, this side effect is not life-threatening 
and may be acceptable for the treatment of highly deadly diseases such as malignant glioma. In conclusion, our 
results reveal a novel function of NA in regulating tumor cell invasion, and support the potential application of 
NA as a therapy for malignant glioma.
Methods
Reagents and cells. High-purity (≥ 99.5%) NA was purchased from Sigma (Cat. # 72309). U251 glio-
blastoma cells and C6 cells were provided by the Cell Bank of Type Culture Collection of Chinese Academy of 
Sciences (Shanghai, China). U251 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Hyclone) 
supplemented with 10% fetal calf serum (Hyclone), and C6 cells in F12K medium (Sigma) supplemented with 
15% equine serum and 2.5% fetal bovine serum (FBS; both sera were from Hyclone). Both cells were incubated at 
37 °C with 30% humidity and 5% CO2.
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Flow cytometry analyses of apoptosis. Cell apoptosis was assessed by using the Annexin-V Apoptosis 
Detection kit (Becton-Dickinson) and following the manufacturer’s instruction. Fluorescence intensity was meas-
ured by a Becton-Dickinson FACSVantageSE flow cytometer. Original data were analyzed by the WinMDI 2.9 
software and presented in the form of dot plots, with fluorescein isothiocyanate (FITC)-conjugated Annexin-V 
as X axis and PI as Y axis.
Invasion assays. Transwell membranes were precoated with 24 mg/ml matrigel (R&D Systems, USA), and 
cells were incubated for 8 hr (for U251 and U87) or 5 days (for B16F10). Cells on the top surface of the insert 
(seeded side) were fixed with methanol, stained with Giemsa solution and counted under a microscope in 5 ran-
domly selected fields (200× ). Alternatively, cells on the seeded side were removed with a cotton swab, and cells 
adhering to the lower surface were fixed, stained and counted.
Immunocytochemistry. U251 cells were cultured on Lab-Tek chamber slides (Sigma). After treatment 
with PBS or NA, the cells were fixed with 4% paraformaldehyde and permeabilized with 0.4% Triton X-100 
at room temperature. The cells were then blocked with 5% bovine serum albumin (BSA; Sigma) and incu-
bated with the primary antibody at 4 °C overnight. Primary antibodies used were: β -tubulin (BD Transduction 
Laboratories™ 556321, 1:400), E-cadherin (BD Transduction Laboratories™ 610181, 1:400), and ZO-1 (Abcam 
ab59720, 1:50). The cells were subsequently incubated with PE or FITC-conjugated secondary antibody (Santa 
Cruz Biotechnology) at room temperature, and labeled with DAPI (Sigma) to identify cell nuclei67. F-actin stress 
fibers were labeled with Rhodamine phalloidin (Invitrogen Life Technologies R415, 5 units/ml) in PBS for 15 min 
at room temperature as described17. Fluorescence was detected using an Olympus IX81S1F-3 laser confocal scan-
ning microscope.
RT-PCR. The mRNA levels of target genes were analyzed using semi-quantitative RT-PCR. Total RNA was 
extracted from U251 cells with an RNA Simple total RNA kit (Tiangen, Beijing, China), and reverse transcrip-
tion was performed using the M-MLV first strand kit (Invitrogen). Reverse transcription products were then 
amplified by semi-quantitative PCR using the HotStart Taq master mix kit (Tiangen). Following a “hot start” at 
95 °C for 3 min, samples were cycled at 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 20 s. The total numbers of cycles 
used were: 26 cycles for E-cadherin, 28 cycles for snail1 and 20 cycles for GAPDH. The samples were then given 
a final 5 min extension at 72 °C. RT-qPCR was carried out with the SYBR Green master mix (Thermo Fisher 
Scientific), and samples were analyzed using a QuantStudio™ 7 Flex Real-Time PCR System. Following a “hot 
start” at 50 °C for 2 min and 95 °C for 10 min, samples were cycled at 95 °C for 10 min, 60 °C for 30 s, and 72 °C 
for 30 s for 40 cycles. The samples were then given a final 5 min extension at 72 °C. Primers used for PCR were: 
5′ -CGAGAGCTACACGTTCACGG-3′ (forward) and 5′-GGGTGTCGAGGGAAAAATAGG-3′ (reverse) for 
E-cadherin, 5′ -ACTGCGACAAGGAGTACACC-3′ (forward) and 5′-GAGTGCGTTTGCAGATGGG-3′ (reverse) 
for snail1, and 5′ -TGTGGGCATCAATGGATTTGG-3′ (forward) and 5′-ACACCATGTATTCCGGGTCAAT-3′ 
for GAPDH.
Microinjection of Xenopus embryos and in situ hybridization. In vitro fertilization, embryo cultur-
ing, preparation of mRNA, microinjection, and whole mount in situ hybridization were conducted as described35. 
For each embryo, 70 ng of NA was injected into one blastomere at 2-cells stage17. The gluococorticoid receptor 
(GR) fusion construct for inducible expression of Xenopus Snail1 was prepared and injected as described68, and 
nuclear translocation of Snail1 was induced by addition of dexamethasone at stage 10–10.5. For in situ hybridi-
zation, embryos were collected at desired stages and the probes for msx1, pax3, zic1, snail1 and snail2 were used 
as described previously68–70.
Western blot and IP. Western blot analyses for whole-cell lysates were performed with the following pri-
mary antibodies: E-cadherin (1:5000), Snail1 (Santa Cruz sc-28199, 1:2000), and ZO-1 (1:1000). Detection 
was carried out using HRP-conjugated secondary antibodies and enhanced chemiluminescence substrate (GE 
Healthcare), and the relative signal intensity was measured using ImageJ. Membranes were stripped and reblot-
ted for β -actin (Sigma-Aldrich A5316, 1:1,000) as a loading control. For IP, U251 cells were treated with 100 nM 
MG132 (R&D System) for 8 hr, washed 3 times with fresh PBS, and then cultured overnight (8–12 hr) with NA 
or PBS (control). Cells were subsequently lysed in PBS + 1% NP-40 containing a protease inhibitor cocktail 
(Roche). Cell lysates were incubated on ice with 0.2 μ g anti-Snail1 antibody for 2 hr, followed by a 2-hr incubation 
with protein A–Sepharose beads. Beads were then washed with ice-cold radioimmunoprecipitation assay buffer. 
The bound proteins were dissociated by incubating in SDS-PAGE loading buffer at 95 °C for 10 min and subse-
quently subjected to Western blot analysis. Immunoblotting was performed using the antibody for ubiquitin (Cell 
Signaling Technology, 1:2,000).
To determine the effect of NA on Snail1 in Xenopus, embryos were injected with 70 pg mRNA encoding 
myc-tagged Snail1 with or without 70 ng NA in each blastomere at 2-cell stage and cultured to stage 15–17. 
CNC explants were dissected from these embryos as described previously35,71. Whole-embryos or dissected CNC 
explants were subsequently lysed in modified TNE lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5 mM 
EDTA, and 0.5% Triton X-100) containing protease inhibitor cocktail (Roche), and processed for Western blot 
with an anti-myc antibody (Sigma-Aldrich C3956, 1:10000)35.
Evaluation of C6 cell invasion in rats. A rat glioma model was established to test the in vivo effect of NA. 
The C6 glioma cells were orthotopically injected to the right striatum of Sprague-Dawley (SD) rat brains through 
a pre-settled stainless steel tube. NA and control (PBS) were also injected through the tube. When the treatment 
was completed, the rats were sacrificed by anesthesia overdose and their brain tissues removed and embedded 
immediately in optimal cutting temperature compound. The brain tissues were subsequently cut into slices (7-μ m 
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thick) with a Leica CM1850 cryostat microtome. Brain slices were fixed with 95% ethanol and stained with hema-
toxylin and eosin (both were from Sigma). For immunohistochemistry, brain slices were fixed with 4% para-
formaldehyde for 30 min, followed by blocking with 5% BSA for 1 hr at room temperature. The slices were then 
incubated with rabbit anti-Nestin polyclonal antibody (Millipore) at 4 °C overnight, washed, incubated again with 
phycoerythrin-conjugated secondary antibody (Santa Cruz Biotechnology) for 45 min at room temperature, and 
stained with DAPI to label nuclei. After being sealed with neutral mounting medium (Jiangyuan, Jiangsu, China), 
the slices were observed under an Olympus upright microscope.
Ethics statement. Methods involving live animals were carried out in accordance with the guidelines and 
regulations enacted and enforced by Chinese National Ministry of Science and Technology as well as National 
Ministry of Health. All experimental protocols were approved by the Institutional Lab Animal Ethics Committee 
at Kunming University of Science and Technology, Kunming, China.
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